Canaccord Genuity Reiterates a 'Buy' on AcelRx Pharmaceuticals (ACRX); ARX-01's Phase 3 Study to Commence by Q4 in H1/12
Go back to Canaccord Genuity Reiterates a 'Buy' on AcelRx Pharmaceuticals (ACRX); ARX-01's Phase 3 Study to Commence by Q4 in H1/12| ACELRX PHARMA (NASDAQ: ACRX) | Delayed: 0.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.86 | 52 Week High | $5.88 | |||
| Open | $0.25 | 52 Week Low | $2.40 | |||
| Day High | $0.86 | P/E | N/A | |||
| Day Low | $0.86 | EPS | $-1.50 | |||
| Volume | 8 | |||||
